CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

pharmatemp2018-header.jpg

Programme

If you have any unique case studies or topics you would like to see covered on the agenda please contact the program director below if you have any questions or queries.

Sarah Fal, Programme Director
Email: sarah.fal@arena-international.com
Telephone: +44 (0) 207 9366 945

Overview

    • 07:45 - 08:10
      • Registration and refreshments

        Lanyard Sponsor: GNH INDIA and CLINIGEN

      • 08:10 - 08:15
        • Chair

          Chris Wallace – Senior Director, International Supply Chain Operations, Genzyme

        Chair’s opening remarks

      • 08:15 - 08:45
        • Speaker

          Clemens Twardy – Head of Global Logistics and Distribution, Boehringer Ingelheim

        OPENING KEYNOTE: Discovering Boehringer Ingelheim’s past journey and future ambitions in temperature monitoring

        •Revealing the influencing factors in temperature maintenance based on past and future factors

        •Showcasing what we have achieved in temperature monitoring technology in order to effectively trace products during shipment

        •Speculating what needs to be asked now in terms of future ambition on temperature monitoring and implementing new technologies within the supply chain

        •Find the way best forward

      • 08:45 - 09:15
        • Session Reserved for Sensitech

        • 09:15 - 09:45
          • Speaker

            Italo Rusconi – Global Supply Chain End to End Manager, Takeda Pharmaceuticals

          Taking a holistic view of the supply chain: Takeda approach to E2E Value Stream Management in Supply Chain

          •Looking at objects within the entire supply chain to identify areas in which to concentrate solution efforts

          • Improving and harmonising the Supply Chain: Overview of our fundamental supply chain principles

          •E2E Value Stream Management: Organisational set up to assure clear accountability amongst products and across sites

          •Exploring challenges for a Lean Supply Chain: Reviewing main obstacles and how to overcome them

          •Revealing the main benefits & lessons learned in supply chain management

        • 09:45 - 10:15
          • Session Reserved

          • 10:15 - 10:45
            • Morning refreshments and networking

            • 10:45 - 11:15
              • Speaker

                Florian Sigl – Logistics Operations Leader, GE Healthcare

              Recapping Basic Logistics Planning in Pharmaceutical Distribution to Ensure Key Factors are Not Overlooked

              •Highlighting the basic procedures used to undertake a single logistics plan whilst considering potential set backs.

              • Pinpointing the potential risk associated with outsourcing distribution with focus on temperature maintenance.

              •Distinguishing between ranges 2 to 5 and 2 to 8 as well as their associated logistical difficulties to ensure products are preserved at all touch points in transit.

              •Categorising the 3 stages of logistical planning to ensure effective temperature maintenance: pre-transit, in-transit, post-transit.

            • 11:15 - 12:15
            • Interactive Focus Group: Determining what it takes to fully convert from air to sea freight to convincingly make the change

              The interactive discussion will consist of ideas being collaboratively communicated and drawn up with the ultimate aim of finding the best way of making the change from air to sea freight as the primary mode of transportation. All those attending will leave with a one-page document highlighting the key takeaways from the session. Points to discuss • How are we able to ship more products by sea opposed to air?

              • Considering and identifying cost, quality and service when using both air and sea freight

              • Overcoming obstacles to make the full change from air to sea freight

              • Audience vote: Is the conversion to sea freight a realistic prospect?

            • 12:15 - 12:45
            • Case Study: Finding the Effective Root Cause Investigations of Temperature Excursions to Pinpoint Where Solution Resources Should be Allocated

              •Considering whether GDP regulation is sufficient to guide the Cold Chain effectively as opposed to devising additional requirements to better monitor temperatures in shipment.

              ••Aligning GDP with GCP in temperature maintenance to ensure standards are met from the supply chain through to the end-user.

              • Determining the viability of mutual trust in a space where GDP may not be a priority thus reinforcing the need to set stricter guidelines.

              •Presenting the challenges in compliance with the current GDP standards as an indication of potential difficulties in future compliance.

            • 12:45 - 14:00
              • Lunch and networking

              • 14:00 - 14:30
                • Mutual Trust vs. Set Guidelines: Will Regulators Require Temperature Data during Transit or Will Regulation Be Limited to Packaging Factors?

                  • Considering whether GDP regulation is sufficient to guide the Cold Chain effectively as opposed to devising additional requirements to better monitor temperatures in shipment.

                  •Aligning GDP with GCP in temperature maintenance to ensure standards are met from the supply chain through to the end-user.

                  • Determining the viability of mutual trust in a space where GDP may not be a priority thus reinforcing the need to set stricter guidelines.

                  • Presenting the challenges in compliance with the current GDP standards as an indication of potential difficulties in future compliance.

                • 14:30 - 15:00
                • Collaborative Panel Discussion: Using Local Distribution Agents Whilst Evaluating the Potential for Shared Risk and Reimbursement

                  •Exploring the use of expert local distributors as a means of mitigating the last mile challenge.

                  •Time performance comparison: Can local agents be more effective in speedy delivery than known global shippers?

                  •Reviewing local logistical capabilities in utilising new technologies in response to humanitarian emergencies such as the Ebola crisis.

                  •Allocating responsibility for reimbursement in the case of loss or damage of product in the hands of local agents.

                • 15:00 - 15:30
                  • Formulating Strategy Based on Validation of Packaging and Equipment To Ensure Product Integrity in Distribution

                    •Exposing the implications of packaging waste on the environment to establish potential methods to reduce your carbon footprint.

                    •Considering the legal requirements to release all packaging data on product justification to assess the long term benefits it has on waste prevention.

                    • Clarifying the potential consequences of non-compliance and the impact any fees incurred will have on costs.

                    •Identifying the use of new labeling technologies on product packaging as a means of relaying effective temperature data.

                  • 15:30 - 16:00
                    • Afternoon refreshments and networking

                    • 16:00 - 16:30
                      • Speaker

                        Gianpiero Lorusso – Director of Supply Operations and General Services, Merck Serono

                      Inspecting the Impact of Container Qualification on a Pharmaceutical Manufacturers’ Strategy.

                      • Comparing and contrasting active and passive packaging in terms of efficacy, cost and sustainability.

                      • Assessing the viability of reusing containers in relation to cost, time and environmental impact.

                      • Ensuring full compliance with container-focused regulation under the GDP.

                      • Sharing strategies to ensure full temperature maintenance is facilitated by container design.

                    • 16:30 - 17:15
                      • Speaker

                        Robert Kayum – Associate Director- Quality Systems and Distribution, Biogen

                      Exploring Risk Management in Cold Chain and Pharmaceutical Logistics to Plan Precautionary Measures Accordingly

                      • Determining the reliability of logistics providers in handling products within ranges of 2°-5°, 2°-8° and -20°(Celsius).

                      • Airport transit processes: Assessing what measures should be taken to minimise temperature spikes during tarmac time.

                      • Considering the risks associated with the lack of control (in terms of training, wages, staff turnover) during third party management of pharmaceutical products.

                      • Identifying the points in transit with the highest risk of temperature deviation to pinpoint areas in need of solutions.

                      • Revisiting the ‘last mile’ as the most critical point of the cold chain. Should attention be placed in other risk areas?

                    • 17:45 - 18:30
                      • Chair’s summary and close of conference

                    previousnext